What is the current valuation of the food allergy diagnosis and treatment market?

The market valuation was 32.5 USD Billion in 2024. Read More

What is the projected market size for the food allergy diagnosis and treatment market by 2035?

The market is projected to reach 55.7 USD Billion by 2035. Read More

What is the expected CAGR for the food allergy diagnosis and treatment market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 5.02%. Read More

Which companies are considered key players in the food allergy diagnosis and treatment market?

Key players include Thermo Fisher Scientific, Abbott Laboratories, Danone, Nestle, Bayer AG, Mylan N.V., Aimmune Therapeutics, Allergan, and Horizon Therapeutics. Read More

What are the main applications in the food allergy diagnosis and treatment market?

Main applications include Skin Testing, Blood Testing, Oral Food Challenge, and Patch Testing. Read More

How much revenue is generated from blood testing in the food allergy diagnosis and treatment market?

Blood Testing generated revenues of 10.0 USD Billion in 2024 and is projected to reach 16.0 USD Billion by 2035. Read More

What is the revenue outlook for hospitals as an end-use segment in the food allergy diagnosis and treatment market?

Hospitals generated 10.0 USD Billion in 2024 and are expected to reach 17.0 USD Billion by 2035. Read More

Which type of allergy generates the highest revenue in the market?

Shellfish Allergy generated 10.5 USD Billion in 2024 and is projected to reach 19.4 USD Billion by 2035. Read More

What are the projected revenues for specific IgE testing by 2035?

Specific IgE Testing is expected to generate revenues of 10.2 USD Billion in 2024 and reach 17.0 USD Billion by 2035. Read More

How does the food allergy diagnosis and treatment market's growth compare across different diagnosis methods?

The market for diagnosis methods shows varied growth, with Skin Prick Test projected to grow from 8.1 USD Billion in 2024 to 13.5 USD Billion by 2035. Read More

Food Allergy Diagnosis Treatment Market

ID: MRFR/HC/6093-CR

123 Pages

Vikita Thakur

Last Updated: March 15, 2026

Food Allergy Diagnosis and Treatment Market Research Report By Diagnosis Method (Skin Prick Test, Blood Test, Oral Food Challenge, Elimination Diet), By Treatment Type (Medication, Immunotherapy, Dietary Management, Emergency Treatment Devices), By End User (Hospitals, Clinics, Home Care, Pharmaceutical Companies), By Age Group (Children, Adults, Elderly) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Food Allergy Diagnosis Treatment Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Application (USD Billion)
4.1.1 Skin Testing
4.1.2 Blood Testing
4.1.3 Oral Food Challenge
4.1.4 Patch Testing
4.2 Healthcare, BY End Use (USD Billion)
4.2.1 Hospitals
4.2.2 Diagnostic Laboratories
4.2.3 Home Care Settings
4.2.4 Research Institutions
4.3 Healthcare, BY Type of Allergy (USD Billion)
4.3.1 Peanut Allergy
4.3.2 Milk Allergy
4.3.3 Egg Allergy
4.3.4 Shellfish Allergy
4.4 Healthcare, BY Diagnosis Method (USD Billion)
4.4.1 Skin Prick Test
4.4.2 Specific IgE Testing
4.4.3 Component Resolved Diagnostics
4.4.4 Elimination Diet
4.5 Healthcare, BY Region (USD Billion)
4.5.1 North America
4.5.1.1 US
4.5.1.2 Canada
4.5.2 Europe
4.5.2.1 Germany
4.5.2.2 UK
4.5.2.3 France
4.5.2.4 Russia
4.5.2.5 Italy
4.5.2.6 Spain
4.5.2.7 Rest of Europe
4.5.3 APAC
4.5.3.1 China
4.5.3.2 India
4.5.3.3 Japan
4.5.3.4 South Korea
4.5.3.5 Malaysia
4.5.3.6 Thailand
4.5.3.7 Indonesia
4.5.3.8 Rest of APAC
4.5.4 South America
4.5.4.1 Brazil
4.5.4.2 Mexico
4.5.4.3 Argentina
4.5.4.4 Rest of South America
4.5.5 MEA
4.5.5.1 GCC Countries
4.5.5.2 South Africa
4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Thermo Fisher Scientific (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Abbott Laboratories (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Danone (FR)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Nestle (CH)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Bayer AG (DE)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Mylan N.V. (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Aimmune Therapeutics (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Allergan (IE)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Horizon Therapeutics (IE)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY APPLICATION
6.4 US MARKET ANALYSIS BY END USE
6.5 US MARKET ANALYSIS BY TYPE OF ALLERGY
6.6 US MARKET ANALYSIS BY DIAGNOSIS METHOD
6.7 CANADA MARKET ANALYSIS BY APPLICATION
6.8 CANADA MARKET ANALYSIS BY END USE
6.9 CANADA MARKET ANALYSIS BY TYPE OF ALLERGY
6.10 CANADA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.11 EUROPE MARKET ANALYSIS
6.12 GERMANY MARKET ANALYSIS BY APPLICATION
6.13 GERMANY MARKET ANALYSIS BY END USE
6.14 GERMANY MARKET ANALYSIS BY TYPE OF ALLERGY
6.15 GERMANY MARKET ANALYSIS BY DIAGNOSIS METHOD
6.16 UK MARKET ANALYSIS BY APPLICATION
6.17 UK MARKET ANALYSIS BY END USE
6.18 UK MARKET ANALYSIS BY TYPE OF ALLERGY
6.19 UK MARKET ANALYSIS BY DIAGNOSIS METHOD
6.20 FRANCE MARKET ANALYSIS BY APPLICATION
6.21 FRANCE MARKET ANALYSIS BY END USE
6.22 FRANCE MARKET ANALYSIS BY TYPE OF ALLERGY
6.23 FRANCE MARKET ANALYSIS BY DIAGNOSIS METHOD
6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
6.25 RUSSIA MARKET ANALYSIS BY END USE
6.26 RUSSIA MARKET ANALYSIS BY TYPE OF ALLERGY
6.27 RUSSIA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.28 ITALY MARKET ANALYSIS BY APPLICATION
6.29 ITALY MARKET ANALYSIS BY END USE
6.30 ITALY MARKET ANALYSIS BY TYPE OF ALLERGY
6.31 ITALY MARKET ANALYSIS BY DIAGNOSIS METHOD
6.32 SPAIN MARKET ANALYSIS BY APPLICATION
6.33 SPAIN MARKET ANALYSIS BY END USE
6.34 SPAIN MARKET ANALYSIS BY TYPE OF ALLERGY
6.35 SPAIN MARKET ANALYSIS BY DIAGNOSIS METHOD
6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
6.37 REST OF EUROPE MARKET ANALYSIS BY END USE
6.38 REST OF EUROPE MARKET ANALYSIS BY TYPE OF ALLERGY
6.39 REST OF EUROPE MARKET ANALYSIS BY DIAGNOSIS METHOD
6.40 APAC MARKET ANALYSIS
6.41 CHINA MARKET ANALYSIS BY APPLICATION
6.42 CHINA MARKET ANALYSIS BY END USE
6.43 CHINA MARKET ANALYSIS BY TYPE OF ALLERGY
6.44 CHINA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.45 INDIA MARKET ANALYSIS BY APPLICATION
6.46 INDIA MARKET ANALYSIS BY END USE
6.47 INDIA MARKET ANALYSIS BY TYPE OF ALLERGY
6.48 INDIA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.49 JAPAN MARKET ANALYSIS BY APPLICATION
6.50 JAPAN MARKET ANALYSIS BY END USE
6.51 JAPAN MARKET ANALYSIS BY TYPE OF ALLERGY
6.52 JAPAN MARKET ANALYSIS BY DIAGNOSIS METHOD
6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
6.54 SOUTH KOREA MARKET ANALYSIS BY END USE
6.55 SOUTH KOREA MARKET ANALYSIS BY TYPE OF ALLERGY
6.56 SOUTH KOREA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
6.58 MALAYSIA MARKET ANALYSIS BY END USE
6.59 MALAYSIA MARKET ANALYSIS BY TYPE OF ALLERGY
6.60 MALAYSIA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.61 THAILAND MARKET ANALYSIS BY APPLICATION
6.62 THAILAND MARKET ANALYSIS BY END USE
6.63 THAILAND MARKET ANALYSIS BY TYPE OF ALLERGY
6.64 THAILAND MARKET ANALYSIS BY DIAGNOSIS METHOD
6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
6.66 INDONESIA MARKET ANALYSIS BY END USE
6.67 INDONESIA MARKET ANALYSIS BY TYPE OF ALLERGY
6.68 INDONESIA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
6.70 REST OF APAC MARKET ANALYSIS BY END USE
6.71 REST OF APAC MARKET ANALYSIS BY TYPE OF ALLERGY
6.72 REST OF APAC MARKET ANALYSIS BY DIAGNOSIS METHOD
6.73 SOUTH AMERICA MARKET ANALYSIS
6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
6.75 BRAZIL MARKET ANALYSIS BY END USE
6.76 BRAZIL MARKET ANALYSIS BY TYPE OF ALLERGY
6.77 BRAZIL MARKET ANALYSIS BY DIAGNOSIS METHOD
6.78 MEXICO MARKET ANALYSIS BY APPLICATION
6.79 MEXICO MARKET ANALYSIS BY END USE
6.80 MEXICO MARKET ANALYSIS BY TYPE OF ALLERGY
6.81 MEXICO MARKET ANALYSIS BY DIAGNOSIS METHOD
6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
6.83 ARGENTINA MARKET ANALYSIS BY END USE
6.84 ARGENTINA MARKET ANALYSIS BY TYPE OF ALLERGY
6.85 ARGENTINA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF ALLERGY
6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.90 MEA MARKET ANALYSIS
6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
6.92 GCC COUNTRIES MARKET ANALYSIS BY END USE
6.93 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF ALLERGY
6.94 GCC COUNTRIES MARKET ANALYSIS BY DIAGNOSIS METHOD
6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
6.96 SOUTH AFRICA MARKET ANALYSIS BY END USE
6.97 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF ALLERGY
6.98 SOUTH AFRICA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
6.100 REST OF MEA MARKET ANALYSIS BY END USE
6.101 REST OF MEA MARKET ANALYSIS BY TYPE OF ALLERGY
6.102 REST OF MEA MARKET ANALYSIS BY DIAGNOSIS METHOD
6.103 KEY BUYING CRITERIA OF HEALTHCARE
6.104 RESEARCH PROCESS OF MRFR
6.105 DRO ANALYSIS OF HEALTHCARE
6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
6.111 HEALTHCARE, BY END USE, 2024 (% SHARE)
6.112 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
6.113 HEALTHCARE, BY TYPE OF ALLERGY, 2024 (% SHARE)
6.114 HEALTHCARE, BY TYPE OF ALLERGY, 2024 TO 2035 (USD Billion)
6.115 HEALTHCARE, BY DIAGNOSIS METHOD, 2024 (% SHARE)
6.116 HEALTHCARE, BY DIAGNOSIS METHOD, 2024 TO 2035 (USD Billion)
6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
7.2.2 BY END USE, 2025-2035 (USD Billion)
7.2.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.2.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
7.3.2 BY END USE, 2025-2035 (USD Billion)
7.3.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.3.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
7.4.2 BY END USE, 2025-2035 (USD Billion)
7.4.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.4.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
7.5.2 BY END USE, 2025-2035 (USD Billion)
7.5.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.5.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
7.6.2 BY END USE, 2025-2035 (USD Billion)
7.6.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.6.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
7.7.2 BY END USE, 2025-2035 (USD Billion)
7.7.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.7.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
7.8.2 BY END USE, 2025-2035 (USD Billion)
7.8.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.8.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
7.9.2 BY END USE, 2025-2035 (USD Billion)
7.9.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.9.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
7.10.2 BY END USE, 2025-2035 (USD Billion)
7.10.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.10.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
7.11.2 BY END USE, 2025-2035 (USD Billion)
7.11.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.11.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
7.12.2 BY END USE, 2025-2035 (USD Billion)
7.12.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.12.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
7.13.2 BY END USE, 2025-2035 (USD Billion)
7.13.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.13.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
7.14.2 BY END USE, 2025-2035 (USD Billion)
7.14.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.14.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
7.15.2 BY END USE, 2025-2035 (USD Billion)
7.15.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.15.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
7.16.2 BY END USE, 2025-2035 (USD Billion)
7.16.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.16.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
7.17.2 BY END USE, 2025-2035 (USD Billion)
7.17.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.17.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
7.18.2 BY END USE, 2025-2035 (USD Billion)
7.18.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.18.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
7.19.2 BY END USE, 2025-2035 (USD Billion)
7.19.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.19.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
7.20.2 BY END USE, 2025-2035 (USD Billion)
7.20.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.20.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
7.21.2 BY END USE, 2025-2035 (USD Billion)
7.21.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.21.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
7.22.2 BY END USE, 2025-2035 (USD Billion)
7.22.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.22.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
7.23.2 BY END USE, 2025-2035 (USD Billion)
7.23.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.23.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
7.24.2 BY END USE, 2025-2035 (USD Billion)
7.24.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.24.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
7.25.2 BY END USE, 2025-2035 (USD Billion)
7.25.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.25.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
7.26.2 BY END USE, 2025-2035 (USD Billion)
7.26.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.26.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
7.27.2 BY END USE, 2025-2035 (USD Billion)
7.27.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.27.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
7.28.2 BY END USE, 2025-2035 (USD Billion)
7.28.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.28.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
7.29.2 BY END USE, 2025-2035 (USD Billion)
7.29.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.29.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
7.30.2 BY END USE, 2025-2035 (USD Billion)
7.30.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
7.30.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

Skin Testing
Blood Testing
Oral Food Challenge
Patch Testing

Healthcare By End Use (USD Billion, 2025-2035)

Hospitals
Diagnostic Laboratories
Home Care Settings
Research Institutions

Healthcare By Type of Allergy (USD Billion, 2025-2035)

Peanut Allergy
Milk Allergy
Egg Allergy
Shellfish Allergy

Healthcare By Diagnosis Method (USD Billion, 2025-2035)

Skin Prick Test
Specific IgE Testing
Component Resolved Diagnostics
Elimination Diet

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓